Wilson M, Lucas A, Cameron A, Luo M. Budget impact of adding vedolizumab to a health plan formulary as a first-line biologic option for ulcerative colitis and crohn's disease. Am Health Drug Benefits. 2018 Jul;11(5):253-62.
Harris JB, Ward MA, Schwab P. Is response-guided therapy being applied in the clinical setting? The hepatitis C example. Am Health Drug Benefits. 2015 Feb;8(1):22-8.
Cates S, Santiago OJ, Hersey J, Blitstein J, Kosa K, Singh A, Berman D. Eat Smart, Live Strong intervention increases fruit and vegetable consumption among low-income older adults. Poster presented at the 2014 Society for Nutrition Education and Behavior Conference; July 2014. Milwaukee, WI. [abstract] J Nutr Educ Behav. 2014 Jul; 46(4):S103-4. doi: 10.1016/j.jneb.2014.04.025
Sacco P, Capkun-Niggli G, Zhang X, Jose R. The economic burden of fragile x syndrome: healthcare resource utilization in the United States. Am Health Drug Benefits. 2013 Mar;6(2):73-83.
Lennert B, Bibeau W, Farrelly E, Sacco P, Schoor T. Assessment of treatment patterns and patient outcomes in levodopa-induced dyskinesias (ASTROID): a US chart review study. Am Health Drug Benefits. 2012 Sep;5(6):347-58.
Lee E, Candrilli SD, Roberts CS, Tang SSK, Bassin S, Wong ND. Regional Differences in the Prevalence, Treatment and Control of Hypertension and Dyslipidemia in Us Urban Hispanic Populations Participating in Health Screening Events. Ethn Dis. 2008 Sep 1;18(4):409-14.
Quandt SA, Graham CN, Bell RA, Snively BM, Golden SL, Stafford JM, Arcury TA. Ethnic disparities in health-related quality of life among older rural adults with diabetes. Ethn Dis. 2007;17(3):471-6.
Anderson DW, Calingaert B. Changes in meat and poultry nutrition labeling regulations: implications for nutrition educators. J Nutr Educ Behav. 1994 Jan;26(1):15-9. doi: 10.1016/S0022-3182(12)80829-6